Yahoo
OTC Markets OTCQB - Delayed Quote USD

Protagenic Therapeutics, Inc. (PTIX)

0.6380 -0.0080 (-1.24%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
5,410.6990
5,700.9500
4,526.9740
3,557.7880
4,140.4130
Operating Income
-5,410.6990
-5,700.9500
-4,526.9740
-3,557.7880
-4,140.4130
Net Non Operating Interest Income Expense
37.7010
43.4650
156.7940
48.3340
-463.7050
Other Income Expense
--
132.1410
-630.3170
-46.0510
81.1840
Pretax Income
-5,241.0550
-5,525.3440
-5,000.4970
-3,555.5050
-4,522.9340
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-5,241.0550
-5,525.3440
-5,000.4970
-3,555.5050
-4,522.9340
Diluted NI Available to Com Stockholders
-5,241.0550
-5,525.3440
-5,000.4970
-3,555.5050
-4,522.9340
Basic EPS
-13.13
-15.82
-16.10
-11.48
-17.36
Diluted EPS
-13.13
-15.82
-16.10
-11.48
-17.36
Basic Average Shares
401.6120
349.9960
310.3270
308.4190
263.2280
Diluted Average Shares
401.6120
349.9960
310.3270
308.4190
263.2280
Total Operating Income as Reported
-5,410.6990
-5,700.9500
-4,526.9740
-3,557.7880
-4,140.4130
Total Expenses
5,410.6990
--
--
--
--
Net Income from Continuing & Discontinued Operation
-5,241.0550
-5,525.3440
-5,000.4970
-3,555.5050
-4,522.9340
Normalized Income
-5,292.5890
-5,577.0760
-4,370.1800
-3,509.4540
-4,604.1180
Interest Income
37.7010
43.4650
264.4760
185.7900
33.2070
Interest Expense
--
0
107.6820
137.4560
496.9120
Net Interest Income
37.7010
43.4650
156.7940
48.3340
-463.7050
EBIT
-5,235.0930
-5,525.3440
-4,892.8150
-3,418.0490
-4,026.0220
EBITDA
-5,184.8070
-5,475.0580
-4,864.5970
-3,418.0190
-4,026.0220
Reconciled Depreciation
50.2860
50.2860
28.2180
0.0300
0
Net Income from Continuing Operation Net Minority Interest
-5,241.0550
-5,525.3440
-5,000.4970
-3,555.5050
-4,522.9340
Total Unusual Items Excluding Goodwill
51.5340
51.7320
-630.3170
-46.0510
81.1840
Total Unusual Items
51.5340
51.7320
-630.3170
-46.0510
81.1840
Normalized EBITDA
-5,236.3410
-5,526.7900
-4,234.2800
-3,371.9680
-4,107.2060
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 4/27/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: